Shares of Teva Pharmaceutical Industries have moved -0.2% today, and are now trading at a price of $8.54. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 5,327,197 compared to the stock's average volume of 8,895,356.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. Based in Tel Aviv, Israel the company has 34,004 full time employees and a market cap of $9,566,625,792.
The company is now trading -19.18% away from its average analyst target price of $10.56 per share. The 9 analysts following the stock have set target prices ranging from $8.0 to $14.0, and on average give Teva Pharmaceutical Industries a rating of hold.
Over the last 12 months TEVA shares have declined by -6.0%, which represents a difference of -16.0% when compared to the S&P 500. The stock's 52 week high is $11.45 per share and its 52 week low is $7.09. Based on Teva Pharmaceutical Industries's average net margin growth of 6.9% over the last 6 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) |
|---|---|---|---|
| 2023 | 15,017,000 | -97,000 | -1 |
| 2022 | 14,925,000 | -53,000 | 0 |
| 2021 | 15,878,000 | 456,000 | 3 |
| 2020 | 16,659,000 | -109,000 | -1 |
| 2019 | 16,887,000 | -2,000 | 0 |
| 2018 | 18,271,000 | -184,000 | -1 |
